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Available online 14 June 2014The value of using qualitative research within or alongside randomised controlled trials (RCTs) is
becoming more widely accepted. Qualitative research may be conducted concurrently with pilot or
full RCTs to understand the feasibility and acceptability of the interventions being tested, or to
improve trial conduct. Clinical Trials Units (CTUs) in the United Kingdom (UK) manage large
numbers of RCTs and, increasingly, manage the qualitative research or collaborate with qualitative
researchers external to the CTU. CTUs are beginning to explicitly manage the process, for example,
through the use of standard operating procedures for designing and implementing qualitative
research with trials. We reviewed the experiences of two UK Clinical Research Collaboration
(UKCRC) registered CTUs of conducting qualitative research concurrently with RCTs. Drawing on
experiences gained from 15 studies, we identify the potential for the qualitative research to
undermine the successful completion or scientific integrity of RCTs. We show that potential
problems can arise from feedback of interimor final qualitative findings tomembers of the trial team
or beyond, in particular reporting qualitative findings whilst the trial is on-going. The problems
include:
1. Unplanned modifications of the trial intervention during the full RCT
2. Selection bias and threats to external validity
3. Unblinding of group allocation
4. Breach of participant anonymity and confidentiality in small RCTs
5. Unplanned modifications of the trial processes and procedures
6. Threats to completion of recruitment, retention and outcome measurement.
Wemake recommendations for improving the management of qualitative research within CTUs.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the
CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Keywords:
Qualitative research
Randomised controlled trial
Complex interventions
Trial managementh Research; QM-SOP,
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. This is anopenaccess article un1. Introduction
The UK Medical Research Council framework recom-
mends that both qualitative and quantitative methods are
necessary to evaluate complex interventions [1]. Qualitative
research can beused concurrentlywith a pilot or full randomised
controlled trial [2–4]; for example, to optimise recruitment and
informed consent strategies, to identify the acceptability of theder theCCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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processes of behaviour change (mediators and moderators)
or to help understand trial findings [1,5–7]. Recently, a
systematic mapping review of published qualitative re-
search carried out with randomised controlled trials (RCTs)
was completed [8]. From this exercise an empirically-based
framework was developed for the different aspects of RCTs
addressed by qualitative research. The framework covers
five broad categories: the intervention being tested, trial
design and conduct, trial outcomes, outcome and process
measures and the health condition the intervention was
aimed at.
Clinical Trials Units (CTUs) in the United Kingdom (UK)
manage large numbers of RCTs and, increasingly, manage the
qualitative research, or work with qualitative researchers
external to the CTU. CTUs are beginning to explicitly manage
this process; for example, one CTU has recently produced a
standard operating procedure for undertaking qualitative
research (QM-SOP) with trials. The QM-SOP aims to stan-
dardise to a degree the processes for developing, conducting,
and reporting this qualitative research [9]. In this paper, we
reflect further on how to help ensure that qualitative research
conducted concurrently with either pilot or full RCTs contrib-
utes fully to the conduct of the trial and the interpretation of
findings, without compromising the scientific validity of the
trial. We make recommendations not previously addressed in
the published literature which focus specifically on reporting
the progress and findings of qualitative researchwhilst a trial is
ongoing.Table 1
Studies undertaken in two CTUs where qualitative research was conducted with RC
Trial
identifier
Phase Intervention
A bExternal feasibility study
(in preparation for Study B)
Clinical treatment
B Full RCT Clinical treatment
C Full RCT Clinical treatment
D Full RCT with internal pilot trial. Public health
E Full RCT Public health prevention
F Full RCT with internal pilot trial. Public health prevention
G bExternal pilot trial Clinical treatment
H bExternal pilot trial Clinical treatment
I bExternal pilot trial Clinical treatment
J bExternal pilot trial Clinical treatment
K Full RCT Clinical treatment
L Full RCT Clinical treatment
M Full RCT Clinical treatment
N bExternal pilot trial Clinical intervention
O Full RCT Clinical treatment &
Prevention
a See Table 2 for description of terms.
b The terms external and internal pilot and feasibility studies are used as defined
that is run to test whether the components of the main trial can all work together. A
phase may contribute to the final analysis. An external pilot is a study distinct from2. Methods
The reflectionswe present here are based on the experiences
of two UK Clinical Research Collaboration (UKCRC) registered
CTUs of conducting qualitative research within their units.
Each CTU employs between 40 and 50 staff, including trialists,
statisticians and staffwhohave qualitative research skills.Whilst
both CTUs specialise in RCTs of complex health interventions
(funded in themain by theNational Institute forHealth Research
(NIHR)), the portfolio of work in each is broad-ranging and
includes the evaluation ofmedicinal products and various health
technologies which are not limited to specific clinical conditions
or populations. The aims of the qualitative research undertaken
in both CTUs cover those previously described [8], including
addressing the intervention and trial conduct processes. Three of
this paper's authors have leading roles within these units and
three have undertaken qualitative researchwith these as well as
other CTUs. Our viewpoints are based on extensive experience of
being closely involved with the design and implementation of
qualitative research with publicly funded multi-centre RCTs.
We reviewed 15 studies currently in progress or recently
completed in the two CTUs (Table 1). Nine of these studies
involved a full RCT conducted with concurrent qualitative
research and five involved a pilot RCT conducted with con-
current qualitative research. One study was qualitative
research undertaken prior to an RCT to inform the conduct
of the RCT. The studies were selected to help identify issues
specific to undertaking qualitative research concurrently with
RCTs. Our review comprised assessment of the following: theTs.
Focus of the qualitative research aTiming of reporting of the
qualitative research
Intervention content and delivery Early (i.e. prior to the main
trial commencing)
Intervention content and delivery Mid-RCT
Intervention content and delivery
Trial design, conduct and processes
Mid-RCT
Intervention content and delivery Late
Intervention content and delivery Mid-RCT
Intervention content and delivery Late
Intervention content and delivery
Trial design, conduct and processes
Early (i.e. prior to the main
trial commencing)
Intervention content and delivery
Trial design, conduct and processes
Early (i.e. prior to the main
trial commencing)
Intervention content and delivery
Trial design, conduct and processes
Early (i.e. prior to the main
trial commencing)
Intervention content and delivery
Trial design, conduct and processes
Target condition
Early (i.e. prior to the main
trial commencing)
Intervention content and delivery Mid-RCT
Intervention content and delivery
Trial design, conduct and processes
Target condition
Mid-RCT
Intervention content and delivery Mid-RCT
Trial design, conduct and processes Early (i.e. prior to the main
trial commencing)
Intervention content and delivery Mid-RCT
by previous authors [10] i.e. a pilot trial is a smaller version of the main trial
n internal pilot will be the first phase of the main trial and data from the pilot
, and conducted prior to, the main trial and the data are analysed separately.
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which progress and findings from the qualitative research and
RCT were reported to the staff involved in conducting the RCT,
conducting the qualitative research and overseeing the whole
study; and the timing of reporting the qualitative research in
relation to the conduct of the RCT e.g. whether the findings
were intended to be disseminated before the RCT closed.
3. Results
The 15 studies are described in Table 1. There was variation
between studies in terms of: (1) the purpose of reporting the
qualitative findings to wider teammembers whilst the trial was
on-going; (2) the processes of reporting; and, (3) the impact of
the timing of reporting the qualitative research.
3.1. The purpose of reporting the qualitative ﬁndings whilst the
trial is on-going
In Study A (see Table 1), qualitative research was under-
taken prior to the full RCT to determine participants' views of
the intervention. Interim findings about the intervention were
fed back to the chief investigator and clinical investigators
delivering the intervention at weekly meetings without any
planned purpose to attendance of the qualitative researcher at
the meetings. We identified two potential problems with this
feedback in practice. First, due to the qualitative study's small
sample size and the distinctive clinical features of patients, it
was very difficult tomaintain participant confidentiality. Hence,
by being given access to emerging qualitative findings, there
was the possibility that clinicians providing care could identify
the patients who had been interviewed and could become
aware of the views they had expressed. The problem here is
that study participants agreed to discuss their experiences with
the researcher in the understanding that the findings would be
anonymised but anonymity was difficult to maintain in verbal
feedback meetings with clinical collaborators. In making this
observation, we do recognise that this is a potential problem
in any qualitative study and is not specific to qualitative
studies undertaken to inform RCTS. The second problemwas
that some of the participants who took part in qualitative
research reported struggling to adhere to the intervention
due to poor clinical support and lack of information on initiation
of the treatment. Clinicians providing the intervention changed
their clinical practice during the pilot study to address these
problems. Changes to an intervention may be acceptable during
a pilot trial [1] but are not acceptable during a full trial (Study B)
when the intervention should be developed and stable. Even
during a pilot study, continuousmodification of the intervention
on the basis of feedback from small numbers of participants
could make it difficult to be certain about the nature of the
intervention being evaluated.
In contrast to Study A (above), where interim feedback of
qualitative research findings occurredwithout planned purpose,
in Study C, where qualitative research was undertaken concur-
rently with a full RCT, the purpose of the regular interchanges
between the qualitative researchers and the RCT team was
planned in the qualitative research protocol. The purpose of
feedback of the qualitative findings whilst the trial was in
progresswas to allow the qualitative study to adapt to the needs
of the trial and the trial processes to also be adapted if necessary.In this particular study, difficultieswith follow-updata collection
were identified in the course of the trial and the interview topic
guide was adapted to explore participants' views about this
issue to enable modification of follow-up data processes.
3.2. The processes of reporting
In Study C (above), senior staff in the CTU recognised
that feedback of the qualitative findings to the whole Trial
Management Group (TMG), which included staff delivering
the intervention, might influence intervention delivery when
this was not intended. In response to this, a sub-group of
the TMG was established to engage with the findings of the
qualitative research during the course of the RCT and to
decide on how to implement these findings in accordance
with the trial protocol. The qualitative research revealed that
participants were not engaging with the study intervention
as expected. The establishment of the subgroup allowed a
forum for discussion of issues, such as safety, whilst keeping
the information from TMG members who were delivering the
intervention andwhomight have had an interest inmaximising
the effectiveness of the intervention.
In other studies (e.g. D and F) there was an implicit
assumption that the qualitative findings would be revealed at
the end of the trial to inform interpretation of the trial results,
without any explicit thought given to the potential benefits of
ongoing feedback. In these studies, the qualitative research
tended to appear lower down the TMG meeting agendas than
trial matters, and, when the qualitative research was discussed
in these meetings, discussions tended to focus on progress of
participant recruitment for the qualitative research. There may
have been benefits to having ongoing reporting of the findings
of the qualitative research which were not explored.
3.3. The effect of timing of reporting the qualitative research on
the RCT
There was variation between studies regarding the timing
of completion of the qualitative research in relation to the
completion of the RCT (see Table 2). For external pilot trials
(Studies G, H, I & J), the qualitative research was both
completed and reported ‘early’ in relation to the full RCT; that
is, before the full RCT began. High priority was given in the
TMG to reporting the qualitative findings because acceptability
of the intervention and views on trial processes were key
outcomes of these pilot studies. As the qualitative research and
pilot trial data collection (e.g. on participant recruitment and
retention rates) completed concurrently, the timing of dissem-
ination was uncontentious because the potential influence of
the qualitative research on the conduct of the full trial or the
delivery of the intervention was built into the protocol for the
full RCT. In some studies, particularly those where the full
trial's follow-up period was longer than a year, the qualitative
research was planned to be completed much earlier than the
trial (e.g. Studies K, E and C)— indicated as ‘mid-RCT’ in Table 2.
This timing was identified as having potentially detrimental
implications for the successful completion of the trial in two
studies. This is because there was a conflict between the desire
to disseminate findings from the qualitative research quickly
and the concern expressed by TMGmembers about the impact
this might have on the on-going trial. For example, in Study K
Table 2
Timing of reporting the qualitative research.
Timing in relation to the main trial Advantage Risks
Early — before participant recruitment in
the main trial or in pre-trial pilot and
feasibility studies
Informs recruitment strategy
Informs intervention delivery
Informs outcome measures
Depends on the aim of the qualitative
research but may miss opportunity to
get full insight into participants' views
& experiences, if the pilot study is small
and there is no further qualitative research
concurrent with the definitive trial
Mid RCT — whilst recruitment and / or
intervention delivery is on going in
the main RCT
Concurrent data collection that enables
modifications to qualitative research
and/or the trial conduct e.g questions
to be expanded/changes in data
collection process
Alters trial protocol e.g. recruitment
strategy — affects trial integrity
Late — at the end of the main RCT when
outcome measures completed
Doesn't impact on trial integrity Too late to follow up any issues regarding
recruitment, adherence etc within the trial.
May rely on retrospective accounts which
can be subject to recall bias
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intervention was unpopular with and poorly adhered to by
participants. As trial recruitment was still open, there was
concern that reporting of these findings to trial staff might
compromise recruitment due to de-motivation of the recruiting
staff. In Study E, the concern was that putting findings about
problems expressed about the intervention into the public
domain might lead to demoralisation of participants and affect
outcome assessment and attrition. Where reporting of the
qualitative research was undertaken mid-RCT and qualitative
research staff were on short-term contracts (e.g. Study K), they
were not funded towards the end of the trial to help interpret the
trial results.
4. Discussion
Timely reporting of interim findings from qualitative
research undertaken concurrently with external pilot trials
may lead to valuable adaptations to the intervention or the
trial protocol during the pilot as well benefitting the sub-
sequent full RCT. Reporting of interim findings whilst a trial
is in progress may be helpful but has the potential to damage
the integrity of the trial. This may be particularly the case if
the qualitative research identifies negative issues about the
intervention. Indeed, researchers have previously made calls
for process evaluation data committees in community inter-
vention RCTS to make decisions on emerging findings from
qualitative research to ensure that data from process evalua-
tions provide a source of insight for the RCT rather than a point
of contention [11]. There may even be a case for submission of
findings from qualitative studies to Data Ethics andMonitoring
Committees where emerging findings indicate potential harm
to participants.
COREQ criteria were developed because of the need for
a CONSORT-equivalent for qualitative research [12] and are
valuable in guiding researchers in reporting qualitative
research after study completion. COREQ is intended to be
“a formal reporting checklist for in-depth interviews and
focus groups” [12] covering important aspects of the study,
including the composition of the research team, study methods,
study context, findings, analysis and interpretations. There have
also been recommendations for reporting the results of qualita-
tive studies carried out alongside trials of complex interventionswithin systematic reviews of effectiveness to explain hetero-
geneity of trial results [13]. However, there is no guidance in
relation to communication of findings whilst the trial is in
progress. Given that it is recommended that process evalua-
tions (which include qualitative research) are analysed prior to
the completion of the RCT analysis [14], we have identified a
number of potential risks related to feedback of interim or final
qualitative findings to members of the trial team, which may
include the chief investigator and those delivering the inter-
vention. These risks and their potential consequences relate to
feedback on participants' views of the interventions as well as
feedback on participant views of the research procedures.
Feedback regarding participants' views of the interven-
tions may compromise the integrity of the trial in three ways:
First, knowledge of dissatisfaction with, or acceptability
of, the intervention may result in attempts by the team
(consciously or unconsciously) to adapt or improve the
intervention. Such changes may be acceptable as part of a
feasibility or pilot trial where development of the interven-
tion is an aim of the study but is unlikely to be acceptable
within a pragmatic phase III trial of effectiveness. Improving
the intervention during the course of the RCT is problematic
in a number of ways. It makes it difficult to replicate the
intervention if it is being modified in an ad hoc manner. In
addition, the trialled intervention may be nearer to an ideal
model rather than the intervention as it can be delivered in
routine practice.
Second, knowledge that adherence to, or acceptability of, the
intervention differs between specific participant sub-groups
(e.g. more severely ill, older or younger participants) may
bias participant recruitment in favour of particular groups
compromising the external validity of the trial population.
Third, none of the trials included in this paperwere blinded.
However, from the experience of this review and particu-
larly from Study A, we propose that, in a blinded trial, there
is potential for feedback of participant views to result in
unblinding. It is likely that qualitative researchers could be
aware of the group allocation of individual participants or
may become aware during the discussion of participants'
experiences. It is therefore important that this knowledge is
342 C. Cooper et al. / Contemporary Clinical Trials 38 (2014) 338–343not unintentionally relayed to the trial investigators. This
could occur where participants are known to the investiga-
tors and where feedback includes comments on symptoms
or characteristics of the intervention which may reveal the
group allocation. For example, in a trial involving surgery
and sham surgery, discussion of wound healing may reveal
the group and discussion of personal or social circum-
stances may reveal the individual.
Feedback on participant views of the research procedures
may compromise the integrity of the trial as it may result in
changes to those procedures e.g. to methods of participant
recruitment, follow-up or use of outcome measures. There
are circumstances where this might improve the trial but the
amendments should be explicit and transparent.
Public dissemination of the findings fromaqualitative study
whilst a trial is on-going could hinder participant recruitment,
retention and outcome measure collection. The timing of the
qualitative study is an important factor in this respect. Where
the qualitative study completes towards the end of the trial
then there is unlikely to be conflict about publication [6,15].
In addition, feedback of participant views and experiences
may compromise participant confidentiality where the char-
acteristics of the participants or condition or participants'
responses to the intervention are idiosyncratic e.g. in a trial of
the mode of insulin delivery where an individual participant is
known to have a complex set of symptoms such as needle
phobia and depression.
4.1. Strengths and limitations
This study is based on 15 studies in 2 CTUs only. The studies
reflect a wide range of clinical interventions and populations
although specific details of the studies have not been revealed
in order to maintain their anonymity. The portfolios of the 2
CTUs are wide ranging and include behavioural, educational,
public health, drug and device studies. It is therefore likely that
the experiences reported here will be of relevance to other
CTUs.
4.2. Recommendations
We recommend that the following be considered and
documented where appropriate within the RCT and qualitative
research protocols:
Consider whether it is intended that the qualitative research
will be used to adapt, amend or refine either the intervention
or aspects of trial conduct during the trial. If this is intended,
this should be made explicit and the processes by which it
will occur should be clear before the trial commences.
Consider the following: the timing, process and purpose
of reporting of interim and final qualitative findings to the
research team and to the public; whether the whole trial
team, TMG or Trial Steering Committee (TSC) needs to
have access to this information; whether there is potential
for reporting to bias the RCT; whether there is potential
for reporting to jeopardise the continuing conduct of the
trial.If it is likely that reporting of interim or final findings may
be contentious, a sub group should be identified to decide
on issues arising from the qualitative research. In cases
where the qualitative study and research staff contracts
finish early in the trial, a publication committee (containing
people unlikely to be biased by exposure to findings) to
discuss authorship and if and when findings can be put into
the public domain may be essential.
Consideration should also be given to the order of items
on the TSC and TMG agenda regarding the trial and the
qualitative research to ensure that sufficient time is given
to each at relevant stages of the study.
Consider the timing of the conduct of the qualitative
research in relation to the RCT and potential impact on
the availability of qualitative staff. If qualitative staff are
not available at the endof the RCT thismayhave implications
for writing a coherent and integrated report. An RCT with a
qualitative study running concurrently should have at least
one qualitative researcher as a part of the investigative
team who is committed to the study from start to finish.
This should be factored into the resources at the proposal
submission stage.
5. Conclusion
CTUs registered with the UKCRC are expected to have
the infrastructure, procedures and expertise to deliver
high quality trials. In reviewing our experience of conducting
qualitative research concurrently with trials, we have identi-
fied some potential problems which could be avoided by
consideration and documentation of issues before starting
the trial. These relate particularly to clarifying whether the
qualitative research is intended to be used to adapt the
intervention or trial protocol and how findings from the
qualitative research will be fed back to the trial team and the
public.
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